Biogen Investment Purchases decreased by 35.9% to $748.80M in Q1 2026 compared to the prior quarter. Over 3 years (FY 2021 to FY 2024), Investment Purchases shows a downward trend with a -100.0% CAGR.
An increase may indicate a strategy to earn interest on excess cash, while a decrease may suggest a need for cash for operations or debt repayment.
This metric captures the cash outflow for the purchase of marketable securities, such as stocks, bonds, or other financi...
Standard for large-cap companies with significant cash reserves; peers manage these portfolios to balance liquidity needs with yield generation.
purchases_of_investments| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $713.60M | $745.70M | $1.44B | $1.13B | $1.18B | $494.30M | $642.60M | $1.32B | $2.80B | $1.02B | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $1.17B | $748.80M |
| QoQ Change | — | +4.5% | +92.6% | -21.1% | +3.9% | -58.0% | +30.0% | +105.6% | +111.9% | -63.5% | -100.0% | — | — | — | — | — | — | -35.9% |
| YoY Change | — | — | — | — | +65.1% | -33.7% | -55.3% | +16.6% | +137.6% | +106.4% | -100.0% | -100.0% | -100.0% | -100.0% | — | — | — | — |